Fertilization in Vitro
27
5
5
14
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.7%
1 terminated out of 27 trials
93.3%
+6.8% vs benchmark
7%
2 trials in Phase 3/4
0%
0 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (27)
Interest of Audiovisual Distraction in the Management of Anxiety and Pain During Oocyte Retrieval
BEst Size for Ovulation Triggering in Poseidon 4 Patients (BEST 4 Study)
SISTER: Sibling Oocyte Insemination With Frozen Sperm From Third Party Donors: Evaluation of Reproductive Techniques
Advantages of Early Intrauterine Transfer of "Blank" Culture Medium Prior to 1st or 2nd Transfer of Thawed Embryo(s).
Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Accumulation for PGT-A.
Oocyte Retrieval and Virtual Reality (REVPO)
Ejaculation Abstinence Time and Assisted Reproductive Technology Outcomes
IVF Failure and Pregnancy Loss on Couples' Psychological Stress
Post-Marketing Surveillance of the Safety and Efficacy of Orgalutran (Ganirelix)®
Does Sexual Intercourse Affect the Outcomes of Frozen-thawed Embryo Transfer?
The Impact of the Timing of Trigger on IVF Success
Effect of Prophylatic Use of Enoxaparin in Women Undergoing in Vitro Fertilization Treatment
Effectiveness of Hypnosis Via Virtual Reality During Oocyte Retrieval
Designated Drug Use Investigation 1 of Follistim Injection (Study P06130)(COMPLETED)
Plasticizers and in Vitro Fertilization Outcomes
Poor Ovarian Responders Undergoing IVF Using Luteal Ovarian Stimulation Versus Follicular Ovarian Stimulation
Virtual Reality-Supported Hypnofertility
The Comparison of Granulosa Cell Apoptosis Rates With or Without Luteinizing Hormone Administration in Poor Responders.
Immediate Versus Delayed FET Following a Stimulated IVF Cycle
Oral Dydrogesterone vs. Micronized Vaginal Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer Cycles